Difference between revisions of "DTI MRI Biomarker Ctte"
Jump to navigation
Jump to search
Line 14: | Line 14: | ||
<br />Note: notes are posted after they are approved by the DTI+ BC during the following t-con | <br />Note: notes are posted after they are approved by the DTI+ BC during the following t-con | ||
+ | *[[Media:2020_11-02_QIBA_DTI-MR_BC_Call_Summary-FINAL.pdf|November 2, 2020]] | ||
*[[Media:2020_10-05_QIBA_DTI-MR_BC_Call_Summary-FINAL.pdf|October 5, 2020]] | *[[Media:2020_10-05_QIBA_DTI-MR_BC_Call_Summary-FINAL.pdf|October 5, 2020]] | ||
*[[Media:2020_05-14_QIBA_DTI-MR_BC_Call_Summary-FINAL.pdf|May 14, 2020]] | *[[Media:2020_05-14_QIBA_DTI-MR_BC_Call_Summary-FINAL.pdf|May 14, 2020]] |
Revision as of 15:50, 21 December 2023
- Co-chairs: Walter Schneider, PhD; Christopher Whitlow, MD, PhD
- RSNA Staff Support: Susan Stanfa
Project Snapshot
Develop a quantitative imaging profile for Diffusion Tensor Imaging MRI.
DTI+ MR Meetings
Recent Approved call summaries:
Note: notes are posted after they are approved by the DTI+ BC during the following t-con
Earlier materials can be found on the [(Perfusion, Diffusion and Flow) Biomarker Committee] page